Glutamine and Antioxidants in the Critically Ill Patient: A Post Hoc Analysis of a Large-Scale Randomized Trial

Journal of Parenteral and Enteral Nutrition

Volumn 39, Issue 4, 2015, Pages 401-409

  Heyland, Daren K ^a   Elke, Gunnar ^b   Cook, Deborah ^c   Berger, Mette M ^d   Wischmeyer, Paul E ^e   Albert, Martin ^f   Muscedere, John ^a   Jones, Gwynne ^g   Day, Andrew G ^a  

^a KINGSTON GENERAL HOSPITAL   (Canada)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c MCMASTER UNIVERSITY   (Canada)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

Author keywords

antioxidants; critical care; glutamine; post hoc analysis; randomized clinical trials

Indexed keywords

ANTIOXIDANT; GLUTAMINE; PLACEBO;

ADULT; AGED; APACHE; ARTICLE; ARTIFICIAL FEEDING; ARTIFICIAL VENTILATION; CHARLSON COMORBIDITY INDEX; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIALYSIS; DIET SUPPLEMENTATION; DRUG MEGADOSE; EUROPE; FOLLOW UP; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MIDDLE AGED; MORTALITY; MULTIPLE ORGAN FAILURE; NORTH AMERICA; NUTRITION; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ADVERSE EFFECTS; CRITICAL ILLNESS; DIETARY SUPPLEMENT; HOSPITAL MORTALITY; KIDNEY; ODDS RATIO; PROSPECTIVE STUDY; STATISTICAL MODEL;

AGED; ANTIOXIDANTS; CRITICAL ILLNESS; DIETARY SUPPLEMENTS; GLUTAMINE; HOSPITAL MORTALITY; HUMANS; KIDNEY; LOGISTIC MODELS; MIDDLE AGED; MULTIPLE ORGAN FAILURE; ODDS RATIO; PROSPECTIVE STUDIES;

EID: 84930520811     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607114529994     Document Type: Article

References (27)

1. Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Kinoshita Y, Ogawa H. Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med. 2003 ; 31: 1048-1052
2. Alonso de Vega JM, Díaz J, Serrano E, Carbonell LF. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med. 2002 ; 30: 1782-1786
3. Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med. 1995 ; 23: 646-651
4. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002 ; 360: 219-223
5. Goodyear-Bruch C, Pierce JD. Oxidative stress in critically ill patients. Am J Crit Care. 2002 ; 11: 543-561
6. Planas M, Schwartz S, Arbos MA, Farriol M. Plasma glutamine levels in septic patients. JPEN J Parenter Enteral Nutr. 1993 ; 17: 299-300
7. Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentration of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med. 1996 ; 24: 392-397
8. Oehler R, Pusch E, Dungel P, et al. Glutamine depletion impairs cellular stress response in human leucocytes. Br J Nutr. 2002 ; 87: S17 - S21
9. Roth E, Funovics J, Muhlbacher F, Schemper M, Mauritz W, Sporn P. Metabolic disorders in severe abdominal sepsis: glutamine deficiency in skeletal muscle. Clin Nutr. 1982 ; 1: 25-41
10. Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel JHI, Zandstra DF. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med. 2001 ; 27: 84-90
11. Novak F, Heyland DK, Avenell A, Novak F, Drover J, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med. 2002 ; 30: 2022-2029
12. HeylandDKDhaliwalRDroverJWGramlichLDodekP, for the Guidelines Committee. Canadian clinical practice guidelines for nutrition support in the adult critically ill patient. JPEN J Parenter Enteral Nutr. 2003;27:355-373. See www.criticalnutrition.com/clinicalpracticeguidelines for the most current version of the glutamine meta-analysis. Accessed August 1, 2013.
13. Heyland DK, Muscedere J, Wischmeyer P, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013 ; 368 (16). 1489-1497
14. Heyland DK, Dhaliwal R, Day A, et al. REducing Deaths due to OXidative Stress: The REDOXS© Study: rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically ill patients. Proc Nutr Soc. 2006 ; 65 (3). 250-263
15. Hamwi GJ Diabetes Mellitus: Diagnosis and Treatment. Danowski TS, ed. New York, NY: American Diabetes Association ; 73-78.
16. Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P. Canadian clinical practice guidelines for nutrition support in the adult critically ill patient. JPEN J Parenter Enteral Nutr. 2003 ; 27: 355-373
17. Kalbfleisch JD, Prentice RL The Statistical Analysis of Failure Time Data. New York, NY: John Wiley ; 1980 :
18. Johnson CC, Fordyce FM, Rayman MP. Symposium on 'Geographical and geological influences on nutrition': factors controlling the distribution of selenium in the environment and their impact on health and nutrition. Proc Nutr Soc. 2010 ; 69: 119-132
19. Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ. 2010 ; 340: c117
20. Heyland DK, Dhaliwal R, Day A, Drover J, Cote H, Wischmeyer P. Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase I dose finding study. JPEN J Parenter Enteral Nutr. 2007 ; 31 (2). 109-118
21. Rodas PC, Rooyackers O, Hebert C, Norberg A, Wernerman J. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci. 2012 ; 122: 591-597
22. Brunet S, Leblanc M, Geadah D, Parent D, Courteau S, Cardinal J. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis. 1999 ; 34: 486-492
23. Angstwurm MW, Schottdorf J, Schopohl J, Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med. 1999 ; 27: 1807-1813
24. Angstwurm MW, Engelmann L, Zimmermann T, et al. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med. 2007 ; 35 (1). 118-126
25. Mishra V, Baines M, Perry SE, et al. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr. 2007 ; 26 (1). 41-50
26. Mashour S, Turner JF, Merrell R. Acute renal failure, oxalosis, and vitamin C supplementation: a case report and review of the literature. Chest. 2000 ; 118: 561-563
27. Bollhalder L, Pfeil AM, Tomonaga Y, Schwenkglenks M. A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clin Nutr. 2013 ; 32: 213-223